Tag Archives: united states
Are People Living with Dementia Being Conned Out of Billions of Dollars in the United States and Around the World?
This is good news for existing Alzheimer’s patients, and the over 1,200 new patients, on average, being diagnosed with Alzheimer’s each day…
Several new companies have received approval from the FDA to sell the generic.
- Sandoz has launched generic versions of treatments for Alzheimer’s disease, the generic pharmaceuticals division of Swiss drug maker Novartis said Wednesday.
- Teva Announces Launch of Generic Aricept in the United States
- Actavis’ generic Aricept gets FDA nod
You should be able to get the generic version of Aricpet within the next week. The drug has shipped.
For those paying full retail or those that are falling into the Medicare donut hole this is wonderful news.
The new price is more than 40 percent lower than the existing price.
Expect the price to fall dramatically after the six month exclusivity period.
Their will be fierce competition in the Generic Aricept marketplace.
We just received the news that Ranbaxy is ready to launch the sale of the Aricept genric in the United States.
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL has received final approval from the U.S. Food and Drug Administration to manufacture and market Donepezil Hydrochloride Tablets 5 mg and 10 mg with 180-day market exclusivity in the U.S. healthcare system.
Good news on Aricept, major price relief coming soon.
Plus, new formulations of Aricept and Namenda offer great promise.
I am getting a lot of search hits from Google on the articles I wrote about generic Aricept and Namenda previously.
I decided to put up an update that includes the currrent state of affairs on the patent expiration for both Aricept and Namenda and when the generic formulation will be available to consumers in the United States.
Original content Bob DeMarco, the Alzheimer’s Reading RoomRead more at www.alzheimersreadingroom.com